These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-003644-59 A two months study of the utility of Elidel cream 1% (pimecrolimus) in the long term management of atopic hand eczema. not-yet-due
No trial status on register 2005-004151-35 Pharmacokinetics of oral cefuroxime-axetil compared to intravenous cefuroxime in term neonates and possible adjustment of the oral therapy bad-data
Not reported 2005-004677-20 Randomised Phase II/III Study on Sectional Single Agent Gemcitabine and Docetaxel Versus Carboplatine / Gemcitabine Doublet Therapy, both combined Cetuximab in the Treatment of Advanced NSCLC (Stage I... 2013-09-25 due-trials
Completed, but no date 2005-005471-15 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts chronic allograft nephropathy bad-data
Ongoing 2006-001935-23 Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts vascular allograft nephropathy not-yet-due
Ongoing 2006-004349-41 Supportive Schmerztherapie-Studie - Einfluss von Physostigmin auf die patientenkontrollierte Analgesie (PCA) in der postoperativen Phase bei Intensivpatienten not-yet-due
Not reported 2006-004977-91 Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämodynam... 2008-03-01 due-trials
Not reported 2007-000624-40 PHASE II STUDY TO EVALUATE GLIVEC (IMATINIB MESYLATE) TO INDUCE PROGRESSION ARREST IN AGGRESSIVE FIBROMATOSIS / DESMOID TUMORS NOT AMENABLE TO SURGICAL RESECTION WITH R0 INTENT OR ACCOMPANIED BY UNACC... 2015-09-30 due-trials
Completed, but no date Terminated 2007-004603-35 Radiotherapy (IMRT), Erbitux And Chemotherapy For Unresectable Carcinomas Of Head and Neck. REACH-Study bad-data
Not reported 2007-006014-41 Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients with Peripheral Artery ... 2010-11-17 due-trials
Ongoing 2007-007792-17 Vasovist®-enhanced MRI in Preoperative Lymph Node Staging of Lung Cancer: Comparison with 18F FDG PET/CT not-yet-due
Not reported Terminated 2008-000121-19 A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either Ext... 2010-05-14 due-trials
Not reported Terminated 2008-001787-36 Verbessert die perioperative Applikation von Esketamin in subanästhetischer Dosierung die postoperative Analgesie? 2011-02-28 due-trials
Ongoing 2009-009426-81 Contrast-enhanced Imaging of the Abdomen: Gadovist® vs. Dotarem® – Intraindividual comparison of 0.1mmol/kg bw gadoterate meglumine with 0.1mmol/kg bw gadobutrol for dynamic abdominal imaging in patie... not-yet-due
Not reported 2009-011095-30 Intra-individual comparison of Gd-EOB-DTPA disodium (Primovist) and Gadobutrol (Gadovist) in patients with suspicion of hepatocellular carcinoma 2013-08-08 due-trials
Completed, but no date 2009-016489-10 Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced ... bad-data
Not reported 2010-019748-38 Hautveränderungen bei Patienten mit Kopf- und Halstumor unter kombinierter RadioImmuno-(chemo)-therapie mit Erbitux® 2015-11-04 due-trials
Listed as ongoing, but also has a completion date 2011-000440-22 Multicenter prospective trial estimating the persistence of molecular remission in chronic myeloid leukemia after stopping TKI 2017-11-20 bad-data
Not reported Terminated 2011-003745-18 A PHASE II WINDOW-OF-OPPORTUNITY STUDY OF 2016-12-31 due-trials
Ongoing 2012-005846-39 Phase II, multicenter, open-label, single-arm trial in advanced and relapsed Angiosarcomas, to evaluate the efficacy of pazopanib (Votrient) in combination with standard of care treatment paclitaxel (... not-yet-due
Ongoing 2014-000924-11 Phase IIA Study on therapy with the NF-kB inhibiting and apoptosis inducing drug dimethylfumarate (DMF) in Patients with Cutaneous T cell lymphoma. not-yet-due
Completed, report not yet due 2015-001309-14 Comparison of the efficacy of using a human acellular dermis (Epiflex®) against the surgical standard procedure for closing an open abdomen with respect to avoiding ventral hernia. 2019-05-02 not-yet-due
Ongoing 2015-004998-33 Multicenter prospective trial after first unsuccesful treatment discontinuation in chronic myeloid leukemia estimating the efficacy of nilotinib in inducing the persistance of molecular remission afte... not-yet-due
Ongoing 2017-000514-35 Prospective Randomised Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) not-yet-due